Impact of mold infections in explanted lungs on outcomes of lung transplantation

Transplantation

Volumn 89, Issue 2, 2010, Pages 253-260

  Vadnerkar, Aniket ^a   Clancy, Cornelius J ^a,b   Celik, Umit ^a   Yousem, Samuel A ^a   Mitsani, Dimitra ^a   Toyoda, Yoshiya ^c   Nguyen, Minh Ly ^d   Kwak, Eun J ^a   Pilewski, Joseph ^a   Silveira, Fernanda P ^a   Crespo, Maria ^a   Nguyen, M Hong ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Explanted lungs; Fungal infections; Lung transplantation

Indexed keywords

ALEMTUZUMAB; COTRIMOXAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; VALGANCICLOVIR; VORICONAZOLE;

ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE PREDISPOSITION; FEMALE; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LUNG GRAFT REJECTION; LUNG INFECTION; LUNG INJURY; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOULD; MYCETOMA; MYCOSIS; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; RISK FACTOR; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIFUNGAL AGENTS; FEMALE; HEART-LUNG TRANSPLANTATION; HUMANS; INCIDENCE; LUNG; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; MYCOSES; POSTOPERATIVE COMPLICATIONS; PYRIMIDINES; RETROSPECTIVE STUDIES; SURVIVAL RATE; SURVIVORS; TRIAZOLES;

EID: 76649102101     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181c3c417     Document Type: Article

References (11)

1. Orens JB, Estenne M, Arcasoy S, et al. International guidelines for the selection of lung transplant candidates: 2006 update-A consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006; 25: 745-755.
2. Hadjiliadis D, Sporn TA, Perfect JR, et al. Outcome of lung transplantation in patients with mycetomas. Chest 2002; 121: 128-134.
3. Yousem SA. The histological spectrum of chronic necrotizing forms of pulmonary aspergillosis. Hum Pathol 1997; 28: 650-656.
4. De PauwB, Walsh TJ, Donnelly JP, et al. Revised definitionsofinvasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-1821.
5. Flume PA, Egan TM, Paradowski LJ, et al. Infectious complications of lung transplantation. Impact of cystic fibrosis. Am J Respir Crit Care Med 1994; 149: 1601-1607.
6. Helmi M, Love RB, Welter D, et al. Aspergillus infection in lung transplant recipients with cystic fibrosis: Risk factors and outcomes comparison to other types of transplant recipients. Chest 2003; 123: 800-808.
7. Kanj SS, Tapson V, Davis RD, et al. Infections in patients with cystic fibrosis following lung transplantation. Chest 1997; 112: 924-930.
8. Nunley DR, Ohori P, Grgurich WF, et al. Pulmonary aspergillosis in cystic fibrosis lung transplant recipients. Chest 1998; 114: 1321-1329.
9. Maguire CP, Hayes JP, Hayes M, et al. Three cases of pulmonary as-pergilloma in adult patients with cystic fibrosis. Thorax 1995; 50: 805-806.
10. Nguyen MH, Jaber R, Leather HL, et al. Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised hosts. J Clin Microbiol 2007; 45: 2787-2792. (Pubitemid 47417315)
11. Bochud PY, Chien JW, Marr KA, et al. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl J Med 2008; 359: 1766-1777.